| Tbio | Zinc finger protein DZIP1 |
May participate in spermatogenesis via its interaction with DAZ (PubMed:15081113). Has a role in primary cilium formation (PubMed:19852954).
Comments
| Disease | Target Count | P-value |
|---|---|---|
| malignant mesothelioma | 3232 | 6.8e-07 |
| intraductal papillary-mucinous carcinoma (IPMC) | 2989 | 7.6e-07 |
| intraductal papillary-mucinous adenoma (IPMA) | 2955 | 1.6e-06 |
| ovarian cancer | 8520 | 3.6e-06 |
| medulloblastoma, large-cell | 6241 | 4.3e-04 |
| intraductal papillary-mucinous neoplasm (IPMN) | 3291 | 4.3e-04 |
| lung cancer | 4740 | 9.2e-04 |
| cystic fibrosis | 1696 | 1.2e-03 |
| osteosarcoma | 7950 | 1.3e-03 |
| Pick disease | 1894 | 1.5e-03 |
| psoriasis | 6694 | 2.4e-03 |
| adult high grade glioma | 3801 | 4.9e-03 |
| chronic rhinosinusitis | 512 | 7.6e-03 |
| interstitial cystitis | 2312 | 9.2e-03 |
| glioblastoma | 5792 | 2.0e-02 |
| group 3 medulloblastoma | 4104 | 2.6e-02 |
| colon cancer | 1478 | 2.9e-02 |
| severe Alzheimer's disease | 47 | 4.2e-02 |
| Disease | Target Count | Z-score | Confidence |
|---|---|---|---|
| Acrodermatitis enteropathica | 18 | 3.798 | 1.9 |
| Disease | log2 FC | p |
|---|---|---|
| adult high grade glioma | -1.300 | 4.9e-03 |
| chronic rhinosinusitis | -1.621 | 7.6e-03 |
| colon cancer | -1.200 | 2.9e-02 |
| cystic fibrosis | 1.100 | 1.2e-03 |
| glioblastoma | -1.700 | 2.0e-02 |
| group 3 medulloblastoma | -1.700 | 2.6e-02 |
| interstitial cystitis | -1.200 | 9.2e-03 |
| intraductal papillary-mucinous adenoma (... | -2.000 | 1.6e-06 |
| intraductal papillary-mucinous carcinoma... | -2.000 | 7.6e-07 |
| intraductal papillary-mucinous neoplasm ... | -2.000 | 4.3e-04 |
| lung cancer | 1.100 | 9.2e-04 |
| malignant mesothelioma | -1.500 | 6.8e-07 |
| medulloblastoma, large-cell | -1.300 | 4.3e-04 |
| osteosarcoma | 1.423 | 1.3e-03 |
| ovarian cancer | -1.400 | 3.6e-06 |
| Pick disease | -1.100 | 1.5e-03 |
| psoriasis | -1.700 | 2.4e-03 |
| severe Alzheimer's disease | -1.047 | 4.2e-02 |
MQAEAADWFSSMPFQKHVYYPLASGPEGPDVAVAAAAAGAASMACAPPSAASGPLPFFQFRPRLESVDWR 1 - 70 RLSAIDVDKVAGAVDVLTLQENIMNITFCKLEDEKCPHCQSGVDPVLLKLIRLAQFTIEYLLHSQEFLTS 71 - 140 QLHTLEERLRLSHCDGEQSKKLLTKQAGEIKTLKEECKRRKKMISTQQLMIEAKANYYQCHFCDKAFMNQ 141 - 210 AFLQSHIQRRHTEENSHFEYQKNAQIEKLRSEIVVLKEELQLTRSELEAAHHASAVRFSKEYEMQKTKEE 211 - 280 DFLKLFDRWKEEEKEKLVDEMEKVKEMFMKEFKELTSKNSALEYQLSEIQKSNMQIKSNIGTLKDAHEFK 281 - 350 EDRSPYPQDFHNVMQLLDSQESKWTARVQAIHQEHKKEKGRLLSHIEKLRTSMIDDLNASNVFYKKRIEE 351 - 420 LGQRLQEQNELIITQRQQIKDFTCNPLNSISEPKGNPLAWQAFESQPAAPAVPMNAPALHTLETKSSLPM 421 - 490 VHEQAFSSHILEPIEELSEEEKGRENEQKLNNNKMHLRKALKSNSSLTKGLRTMVEQNLMEKLETLGINA 491 - 560 DIRGISSDQLHRVLKSVESERHKQEREIPNFHQIREFLEHQVSCKIEEKALLSSDQCSVSQMDTLSTGEV 561 - 630 PKMIQLPSKNRQLIRQKAVSTDRTSVPKIKKNVMEDPFPRKSSTITTPPFSSEEEQEDDDLIRAYASPGP 631 - 700 LPVPPPQNKGSFGKNTVKSDADGTEGSEIEDTDDSPKPAGVAVKTPTEKVEKMFPHRKNVNKPVGGTNVP 701 - 770 EMFIKKEELQELKCADVEDEDWDISSLEEEISLGKKSGKEQKEPPPAKNEPHFAHVLNAWGAFNPKGPKG 771 - 840 EGLQENESSTLKSSLVTVTDWSDTSDV 841 - 867 //
